BioTime Inc (NYSE American:BTX)

2.31
Delayed Data
As of Apr 23
 -0.04 / -1.70%
Today’s Change
2.10
Today|||52-Week Range
3.50
+7.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues390.0K381.0K1.7M999.0K
 
 
 
 
 
Cost of Goods Sold57.0K5.0K52.0K54.0K
 
 
 
 
 
Depreciation And Amortization818.0K787.0K831.0K860.0K
 
 
 
 
 
 
Operating ExpensesGross Income-485.0K-411.0K805.0K85.0K
 
 
 
 
 
General Expenses10.8M9.9M10.3M9.6M
 
 
 
 
 
Research And Development5.9M5.7M6.0M4.1M
 
 
 
 
 
Total Operating Expenses11.7M10.7M11.2M10.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.3M-10.3M-9.5M-9.6M
 
 
 
 
 
Extraordinary Charge0.000.00-2.8M-67.6M
 
 
 
Pre-Tax Equity Earnings-10.0M-7.7M31.2M0.00
 
 
 
 
Interest Expense On Debt306.0K413.0K10.0K0.00
 
 
 
 
Other Expenses72.4M2.4M-143.0K247.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income50.9M-16.1M18.8M-76.8M
 
 
 
 
 
Income Taxes-3.9M-3.9M-4.8M-4.8M
 
 
 
 
 
Minority Interest-2.3M-576.0K-335.0K-138.0K
 
 
 
 
 
Net Income49.3M-11.7M14.3M-71.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS106.7M110.9M115.3M124.8M
 
 
 
 
 
Shares To Calculate EPS Diluted107.4M110.9M115.3M124.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.46-$0.11$0.12-$0.58
 
 
 
 
 
EPS Diluted$0.46-$0.11$0.12-$0.58